Search research articles
Contact Us
Filters
Showing results (221-230 of 304) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741
Howard L McLeod, Daniel J Sargent, Sharon Marsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer
Daniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.
Cancers
|
May 28, 2020
<i>WRN</i>-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype
Kai Zimmer, Alberto Puccini, Joanne Xiu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
November 22, 2018
Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers
Lara F Nhola, Sahar S Abdelmoneim, Hector R Villarraga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R Pachman, Rui Qin, Drew K Seisler, et al.
Retina (Philadelphia, Pa.)
|
July 14, 2012
A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes
Sarah L Miles, Richard M Niles, Sean Pittock, et al.
Nature Communications
|
January 15, 2025
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.
Nature Communications
|
November 25, 2024
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.
JCO Precision Oncology
|
March 23, 2022
Landscape of <i>KRAS</i><sup>G12C</sup>, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in <i>KRAS</i>-Mutated Cancers
Mohamed E Salem, Sherif M El-Refai, Wei Sha, et al.
The Oncologist
|
January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancer
Richard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 304) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741
Howard L McLeod, Daniel J Sargent, Sharon Marsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer
Daniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.
Cancers
|
May 28, 2020
<i>WRN</i>-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype
Kai Zimmer, Alberto Puccini, Joanne Xiu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
November 22, 2018
Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers
Lara F Nhola, Sahar S Abdelmoneim, Hector R Villarraga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R Pachman, Rui Qin, Drew K Seisler, et al.
Retina (Philadelphia, Pa.)
|
July 14, 2012
A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes
Sarah L Miles, Richard M Niles, Sean Pittock, et al.
Nature Communications
|
January 15, 2025
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.
Nature Communications
|
November 25, 2024
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.
JCO Precision Oncology
|
March 23, 2022
Landscape of <i>KRAS</i><sup>G12C</sup>, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in <i>KRAS</i>-Mutated Cancers
Mohamed E Salem, Sherif M El-Refai, Wei Sha, et al.
The Oncologist
|
January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancer
Richard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Page
of 31